{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:52Z","timestamp":1791493492947,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bleomycin hydrolase (BLMH) is a well-conserved cysteine protease widely expressed in several mammalian tissues. In skin, which contains high levels of BLMH, this protease is involved in the degradation of citrullinated filaggrin monomers into free amino acids important for skin hydration. Interestingly, the expression and activity of BLMH is reduced in patients with atopic dermatitis (AD) and psoriasis, and BLMH knockout mice acquire tail dermatitis. Apart from its already known function, we have discovered a novel role of BLMH in the regulation of inflammatory chemokines and wound healing. We show that lowered BLMH levels in keratinocytes result in increased release of the pro-inflammatory chemokines CXCL8 and GRO\u03b1, which are upregulated in skin from AD patients compared to healthy individuals. Conditioned media from keratinocytes expressing low levels of BLMH increased chemotaxis by neutrophils and caused a delayed wound healing in the presence of low-level TNF\u03b1. This defective wound healing was improved by blocking the shared receptor of CXCL8 and GRO\u03b1, namely CXCR2, using a specific receptor antagonist. Collectively, our results present a novel function of BLMH in regulating the secretion of chemokines involved in inflammation and wound healing in human keratinocytes.<\/jats:p>","DOI":"10.1038\/s41598-019-56667-6","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T11:02:45Z","timestamp":1577790165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-6395","authenticated-orcid":false,"given":"Rebecca","family":"Riise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Odqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Monkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suado M.","family":"Abdillahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tyrchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Muthas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Fahl\u00e9n","family":"Yrlid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"56667_CR1","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","volume":"17","author":"E Proksch","year":"2008","unstructured":"Proksch, E., Brandner, J. M. & Jensen, J. M. The skin: an indispensable barrier. Exp. Dermatol. 17, 1063\u20131072 (2008).","journal-title":"Exp. Dermatol."},{"key":"56667_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molmed.2013.11.005","volume":"20","author":"SJ de Veer","year":"2014","unstructured":"de Veer, S. J., Furio, L., Harris, J. M. & Hovnanian, A. Proteases: common culprits in human skin disorders. Trends Mol. Med. 20, 166\u2013178, https:\/\/doi.org\/10.1016\/j.molmed.2013.11.005 (2014).","journal-title":"Trends Mol. Med."},{"key":"56667_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","volume":"125","author":"PM Elias","year":"2005","unstructured":"Elias, P. M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125, 183\u2013200, https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23668.x (2005).","journal-title":"J. Invest. Dermatol."},{"key":"56667_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1172\/JCI28521","volume":"116","author":"JA Segre","year":"2006","unstructured":"Segre, J. A. Epidermal barrier formation and recovery in skin disorders. J. Clin. Invest. 116, 1150\u20131158, https:\/\/doi.org\/10.1172\/JCI28521 (2006).","journal-title":"J. Clin. Invest."},{"key":"56667_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00441-012-1501-x","volume":"351","author":"AV Rawlings","year":"2013","unstructured":"Rawlings, A. V. & Voegeli, R. Stratum corneum proteases and dry skin conditions. Cell Tissue Res. 351, 217\u2013235, https:\/\/doi.org\/10.1007\/s00441-012-1501-x (2013).","journal-title":"Cell Tissue Res."},{"key":"56667_CR6","doi-asserted-by":"publisher","first-page":"12829","DOI":"10.1074\/jbc.M807908200","volume":"284","author":"Y Kamata","year":"2009","unstructured":"Kamata, Y. et al. Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J. Biol. Chem. 284, 12829\u201312836, https:\/\/doi.org\/10.1074\/jbc.M807908200 (2009).","journal-title":"J. Biol. Chem."},{"key":"56667_CR7","doi-asserted-by":"publisher","unstructured":"Thyssen, J. P. et al. Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice. J. Invest. Dermatol., https:\/\/doi.org\/10.1016\/j.jid.2019.07.716 (2019).","DOI":"10.1016\/j.jid.2019.07.716"},{"key":"56667_CR8","doi-asserted-by":"publisher","first-page":"e0157651","DOI":"10.1371\/journal.pone.0157651","volume":"11","author":"A Jona","year":"2016","unstructured":"Jona, A., Miltenyi, Z., Poliska, S., Balint, B. L. & Illes, A. Effect of Bleomycin Hydrolase Gene Polymorphism on Late Pulmonary Complications of Treatment for Hodgkin Lymphoma. PLoS One 11, e0157651, https:\/\/doi.org\/10.1371\/journal.pone.0157651 (2016).","journal-title":"PLoS One"},{"key":"56667_CR9","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1200\/JCO.2007.14.1606","volume":"26","author":"EC de Haas","year":"2008","unstructured":"de Haas, E. C. et al. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J. Clin. Oncol. 26, 1817\u20131823, https:\/\/doi.org\/10.1200\/JCO.2007.14.1606 (2008).","journal-title":"J. Clin. Oncol."},{"key":"56667_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/80852","volume":"1","author":"L Stoltze","year":"2000","unstructured":"Stoltze, L. et al. Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1, 413\u2013418, https:\/\/doi.org\/10.1038\/80852 (2000).","journal-title":"Nat. Immunol."},{"key":"56667_CR11","doi-asserted-by":"publisher","first-page":"22485","DOI":"10.1074\/jbc.M603656200","volume":"281","author":"J Zimny","year":"2006","unstructured":"Zimny, J., Sikora, M., Guranowski, A. & Jakubowski, H. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J. Biol. Chem. 281, 22485\u201322492, https:\/\/doi.org\/10.1074\/jbc.M603656200 (2006).","journal-title":"J. Biol. Chem."},{"key":"56667_CR12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00726-011-1207-5","volume":"43","author":"K Borowczyk","year":"2012","unstructured":"Borowczyk, K., Tisonczyk, J. & Jakubowski, H. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase. Amino Acids 43, 1339\u20131348, https:\/\/doi.org\/10.1007\/s00726-011-1207-5 (2012).","journal-title":"Amino Acids"},{"key":"56667_CR13","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1096\/fj.99-0938com","volume":"14","author":"IM Lefterov","year":"2000","unstructured":"Lefterov, I. M., Koldamova, R. P. & Lazo, J. S. Human bleomycin hydrolase regulates the secretion of amyloid precursor protein. FASEB J. 14, 1837\u20131847 (2000).","journal-title":"FASEB J."},{"key":"56667_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3233\/JAD-132033","volume":"40","author":"J Suszynska-Zajczyk","year":"2014","unstructured":"Suszynska-Zajczyk, J., Luczak, M., Marczak, L. & Jakubowski, H. Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration. J. Alzheimers Dis. 40, 713\u2013726, https:\/\/doi.org\/10.3233\/JAD-132033 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"56667_CR15","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.96.8.4680","volume":"96","author":"DR Schwartz","year":"1999","unstructured":"Schwartz, D. R. et al. The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc. Natl. Acad. Sci. USA 96, 4680\u20134685 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56667_CR16","doi-asserted-by":"publisher","first-page":"8204","DOI":"10.1074\/jbc.M110.169292","volume":"286","author":"Y Kamata","year":"2011","unstructured":"Kamata, Y. et al. Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis. J. Biol. Chem. 286, 8204\u20138212, https:\/\/doi.org\/10.1074\/jbc.M110.169292 (2011).","journal-title":"J. Biol. Chem."},{"key":"56667_CR17","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.jaci.2014.07.056","volume":"134","author":"L Pellerin","year":"2014","unstructured":"Pellerin, L., Paul, C., Schmitt, A. M., Serre, G. & Simon, M. Bleomycin hydrolase downregulation in lesional skin of adult atopic dermatitis patients is independent of FLG gene mutations. J. Allergy Clin. Immunol. 134, 1459\u20131461 e1457, https:\/\/doi.org\/10.1016\/j.jaci.2014.07.056 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00403-011-1180-6","volume":"304","author":"Y Kamata","year":"2012","unstructured":"Kamata, Y. et al. Expression of bleomycin hydrolase in keratinization disorders. Arch. Dermatol. Res. 304, 31\u201338, https:\/\/doi.org\/10.1007\/s00403-011-1180-6 (2012).","journal-title":"Arch. Dermatol. Res."},{"key":"56667_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/adc.67.3.277","volume":"67","author":"S Sumimoto","year":"1992","unstructured":"Sumimoto, S., Kawai, M., Kasajima, Y. & Hamamoto, T. Increased plasma tumour necrosis factor-alpha concentration in atopic dermatitis. Arch. Dis. Child. 67, 277\u2013279, https:\/\/doi.org\/10.1136\/adc.67.3.277 (1992).","journal-title":"Arch. Dis. Child."},{"key":"56667_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0091-6749(98)70136-8","volume":"102","author":"IJ de Vries","year":"1998","unstructured":"de Vries, I. J. et al. Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J. Allergy Clin. Immunol. 102, 461\u2013468 (1998).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR21","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.2741\/2853","volume":"13","author":"Y Kobayashi","year":"2008","unstructured":"Kobayashi, Y. The role of chemokines in neutrophil biology. Front. Biosci. 13, 2400\u20132407 (2008).","journal-title":"Front. Biosci."},{"key":"56667_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000339666","volume":"160","author":"T Amarbayasgalan","year":"2013","unstructured":"Amarbayasgalan, T., Takahashi, H., Dekio, I. & Morita, E. Interleukin-8 content in the stratum corneum as an indicator of the severity of inflammation in the lesions of atopic dermatitis. Int. Arch. Allergy Immunol. 160, 63\u201374, https:\/\/doi.org\/10.1159\/000339666 (2013).","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"10","key":"56667_CR23","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.3390\/ijms19103217","volume":"19","author":"Anisyah Ridiandries","year":"2018","unstructured":"Ridiandries, A., Tan, J. T. M. & Bursill, C. A. The Role of Chemokines in Wound Healing. Int. J. Mol. Sci., 19, https:\/\/doi.org\/10.3390\/ijms19103217 (2018).","journal-title":"International Journal of Molecular Sciences"},{"key":"56667_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4168\/aair.2018.10.3.207","volume":"10","author":"BE Kim","year":"2018","unstructured":"Kim, B. E. & Leung, D. Y. M. Significance of Skin Barrier Dysfunction in Atopic Dermatitis. Allergy Asthma Immunol. Res. 10, 207\u2013215, https:\/\/doi.org\/10.4168\/aair.2018.10.3.207 (2018).","journal-title":"Allergy Asthma Immunol. Res."},{"key":"56667_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.jid.5700701","volume":"127","author":"SA Eming","year":"2007","unstructured":"Eming, S. A., Krieg, T. & Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 127, 514\u2013525, https:\/\/doi.org\/10.1038\/sj.jid.5700701 (2007).","journal-title":"J. Invest. Dermatol."},{"key":"56667_CR26","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1074\/jbc.M110.185348","volume":"286","author":"T Ratovitski","year":"2011","unstructured":"Ratovitski, T., Chighladze, E., Waldron, E., Hirschhorn, R. R. & Ross, C. A. Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J. Biol. Chem. 286, 12578\u201312589, https:\/\/doi.org\/10.1074\/jbc.M110.185348 (2011).","journal-title":"J. Biol. Chem."},{"key":"56667_CR27","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1021\/bi990135l","volume":"38","author":"RP Koldamova","year":"1999","unstructured":"Koldamova, R. P. et al. Human bleomycin hydrolase binds ribosomal proteins. Biochemistry 38, 7111\u20137117, https:\/\/doi.org\/10.1021\/bi990135l (1999).","journal-title":"Biochemistry"},{"key":"56667_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jlb.56.1.80","volume":"56","author":"N Borregaard","year":"1994","unstructured":"Borregaard, N. et al. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J. Leukoc. Biol. 56, 80\u201387 (1994).","journal-title":"J. Leukoc. Biol."},{"key":"56667_CR29","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.4049\/jimmunol.175.8.5358","volume":"175","author":"I Oynebraten","year":"2005","unstructured":"Oynebraten, I. et al. Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J. Immunol. 175, 5358\u20135369 (2005).","journal-title":"J. Immunol."},{"key":"56667_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1182\/blood-2003-08-2891","volume":"104","author":"I Oynebraten","year":"2004","unstructured":"Oynebraten, I., Bakke, O., Brandtzaeg, P., Johansen, F. E. & Haraldsen, G. Rapid chemokine secretion from endothelial cells originates from 2 distinct compartments. Blood 104, 314\u2013320, https:\/\/doi.org\/10.1182\/blood-2003-08-2891 (2004).","journal-title":"Blood"},{"key":"56667_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","volume":"16","author":"S Barrientos","year":"2008","unstructured":"Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H. & Tomic-Canic, M. Growth factors and cytokines in wound healing. Wound Repair. Regen. 16, 585\u2013601, https:\/\/doi.org\/10.1111\/j.1524-475X.2008.00410.x (2008).","journal-title":"Wound Repair. Regen."},{"key":"56667_CR32","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0002-9440(10)65699-4","volume":"153","author":"E Engelhardt","year":"1998","unstructured":"Engelhardt, E. et al. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am. J. Pathol. 153, 1849\u20131860 (1998).","journal-title":"Am. J. Pathol."},{"key":"56667_CR33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.69.4.513","volume":"69","author":"R Gillitzer","year":"2001","unstructured":"Gillitzer, R. & Goebeler, M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513\u2013521 (2001).","journal-title":"J. Leukoc. Biol."},{"key":"56667_CR34","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/humrep\/dei182","volume":"20","author":"M Berkkanoglu","year":"2005","unstructured":"Berkkanoglu, M. et al. Inhibition of chemokines prevents intraperitoneal adhesions in mice. Hum. Reprod. 20, 3047\u20133052, https:\/\/doi.org\/10.1093\/humrep\/dei182 (2005).","journal-title":"Hum. Reprod."},{"key":"56667_CR35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2567.2001.01228.x","volume":"103","author":"J Reckless","year":"2001","unstructured":"Reckless, J., Tatalick, L. M. & Grainger, D. J. The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo. Immunology 103, 244\u2013254 (2001).","journal-title":"Immunology"},{"issue":"954-964","key":"56667_CR36","doi-asserted-by":"publisher","first-page":"e951","DOI":"10.1016\/j.jaci.2010.12.1124","volume":"127","author":"M Suarez-Farinas","year":"2011","unstructured":"Suarez-Farinas, M. et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J. Allergy Clin. Immunol. 127(954-964), e951\u2013954, https:\/\/doi.org\/10.1016\/j.jaci.2010.12.1124 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR37","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jaci.2012.02.020","volume":"129","author":"A Rebane","year":"2012","unstructured":"Rebane, A. et al. Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J. Allergy Clin. Immunol. 129, 1297\u20131306, https:\/\/doi.org\/10.1016\/j.jaci.2012.02.020 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","volume":"124","author":"E Guttman-Yassky","year":"2009","unstructured":"Guttman-Yassky, E. et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J. Allergy Clin. Immunol. 124, 1235\u20131244 e1258, https:\/\/doi.org\/10.1016\/j.jaci.2009.09.031 (2009).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR39","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","volume":"130","author":"JK Gittler","year":"2012","unstructured":"Gittler, J. K. et al. Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J. Allergy Clin. Immunol. 130, 1344\u20131354, https:\/\/doi.org\/10.1016\/j.jaci.2012.07.012 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"56667_CR40","doi-asserted-by":"publisher","first-page":"e11450","DOI":"10.1371\/journal.pone.0011450","volume":"5","author":"DA Plager","year":"2010","unstructured":"Plager, D. A. et al. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 5, e11450, https:\/\/doi.org\/10.1371\/journal.pone.0011450 (2010).","journal-title":"PLoS One"},{"key":"56667_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-3-19","volume":"3","author":"R Mobini","year":"2009","unstructured":"Mobini, R. et al. A module-based analytical strategy to identify novel disease-associated genes shows an inhibitory role for interleukin 7 Receptor in allergic inflammation. BMC Syst. Biol. 3, 19, https:\/\/doi.org\/10.1186\/1752-0509-3-19 (2009).","journal-title":"BMC Syst. Biol."},{"key":"56667_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/exd.12967","volume":"25","author":"BC Martel","year":"2016","unstructured":"Martel, B. C. et al. Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis. Exp. Dermatol. 25, 453\u2013459, https:\/\/doi.org\/10.1111\/exd.12967 (2016).","journal-title":"Exp. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56667-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56667-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T18:20:35Z","timestamp":1671301235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56667-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56667"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56667-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"assertion":[{"value":"8 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors were employees at AstraZeneca Group while performing this study and may have stock\/stock options in AstraZeneca.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20407"}}